Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
For specific code-level details, or if you have any questions, please visit our Prior Authorizations page or contact our Provider Services Helpline at 1-888-991-9023 (Monday - Friday, 9:00 a.m
doi: 10.1016/s0196-9781(00)00305-3
had current treatment with or history of (within 3 months before visit 2) treatment with medications that may cause substantial weight gain, including but not limited to: tricyclic antidepressants, atypical antipsychotics and mood stabilizers Examples: imipramine amitriptyline mirtazapine paroxetine phenelzine chlorpromazine thioridazine clozapine olanzapine valproic acid (and its derivatives) or lithium Note: selective serotonin reuptake inhibitors other than paroxetine were permitted
Comparative analysis showed that both RGD-GHK and sOtx2-GHK exhibited superior anti-oxidative and anti-apoptotic effects compared to the non-targeting peptide, GHK
US$ 23.05
US$ 20.03
US$ 26.65
US$ 23.05
